LAG3 and neoplasm: For instance, PD-1/LAG-3 are often co-expressed on tumor-infiltrating lymphocytes (TILs) in “inflamed” tumors, where pre-existing immunity is physiologically regulated rather than suppressed (Mollavelioglu et al., 2022).